10/05/2026
In this week’s spotlight, we’d like to recognize the groundbreaking work on inducing ferroptosis, an iron-dependent form of programmed cell death, in regulatory T cells to overcome immune suppression in the tumor microenvironment.
Read the Article here: https://hubs.la/Q04zbbNw0
This research article, "Selective disruption of lipid peroxide homeostasis in intratumoral regulatory T cells by targeting FSP1 enhances cancer immunity," published in Science Advances, investigates how different immune cells uniquely regulate lipid peroxidation. The researchers discovered that intratumoral regulatory T cells (Tregs) are exceptionally vulnerable to ferroptosis. By pharmacologically targeting the enzyme FSP1, they were able to selectively induce ferroptotic cell death in these immunosuppressive Tregs without harming beneficial, cancer-fighting cytotoxic T cells.
To prove that the resulting tumor regression was strictly dependent on this targeted cell death enhancing the cytotoxic immune response in vivo, the authors used Leinco’s in vivo GOLD™ Anti-Mouse CD8b.2 [Clone 53-5.8] to perform targeted CD8+ T cell depletion. Their findings highlight a powerful new strategy for cancer immunotherapy: selectively destroying suppressive cells via ferroptosis while completely sparing effector T cells.
👇Featured products👇
• Anti-Mouse CD8b.2 [Clone 53-5.8]: https://hubs.la/Q04zbbQf0
Deletion of Aifm2 disrupts Treg cell immunosuppression within tumors without inciting autoimmune pathology in mice.
